NeutriSci to Complete Share Settlement

Author's Avatar
Jul 03, 2020
Article's Main Image

VANCOUVER, BC / ACCESSWIRE / July 3, 2020 / NeutriSci International Inc. (the "Company" or "NeutriSci") (TSXV:NU, Financial)(OTCQB:NRXCF)(FRANKFURT:1N9) , an innovative technology company developing products for the nutraceutical industry, announces that it will issue 2,060,534 common shares, at a deemed price of $0.05 per share, in settlement of US$75,833 in consulting services fees for strategic planning, market intelligence initiatives, research, and business referrals owing in connection with an agreement entered into with an arm's length third party on May 29, 2019.